TickerFactsScreenerDevelopers

China SXT Pharmaceuticals, Inc. (SXTC) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2017: $2.57M2018: $3.62M2019: $2.40M2020: $2.46M2021: $1.94M2022: $1.35M2023: $1.55M2024: $1.37M2025: $1.37M$1.37M
2017Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$1.37M-0.1%
2024$1.37M-11.1%
2023$1.55M+14.4%
2022$1.35M-30.3%
2021$1.94M-21.2%
2020$2.46M+2.4%
2019$2.40M-33.6%
2018$3.62M+40.8%
2017$2.57M—